Regulatory

i1-126039-1384786383048.jpg

IDEXX Laboratories Inc. received approval from the U.S. Food and Drug Administration (FDA) to market and sell Surpass? (1% diclofenac sodium) Topical Anti-Inflammatory Cream, a new treatment for horses with pain and lameness due to osteo-arthritis.

i1-126049-1384786347457.jpg

IDEXX Laboratories Inc. received approval from the U.S. Department of Agriculture (USDA) to produce and sell the IDEXX HerdChek? BSE Antigen Test Kit to USDA-approved laboratories.

i1-125986-1384786569400.jpg

NEW YORK - Pfizer Animal Health received approval from the Food and Drug Administration (FDA) for Simplecef? (cefpodoxime proxetil) tablets, the only oral cephalosporin approved to treat canine skin infections (wounds and abscesses) with the ease of once-daily dosing.

LEXINGTON, KY.-The U.S. District Court for the Eastern District of Kentucky issued a seizure warrant Aug. 11 at the request of the Food and Drug Administration (FDA) for various compounded drug products at BET Pharm LLC, in Lexington, Ky.

i1-110711-1384790676909.jpg

ITASCA, ILL.-Equine Data Systems International, Inc. (EDSI) purchased the Equine Data Management Software (EDMS) and all of its related materials.

i1-107537-1384790939872.jpg

WESTBROOK, MAINE-IDEXX Laboratories, Inc., received approval from the U.S. Food and Drug Administration (FDA) to market and sell Surpass? (1% diclofenac sodium) Topical Anti-Inflammatory Cream, a new treatment for horses with pain and lameness due to osteoarthritis.

Washington-As the U.S. Food and Drug Administration's (FDA) labors to restrict compounded drugs for nonfood animals, its efforts are preceded by a 2002 Supreme Court case in which justices criticized the agency for restricting pharmacists' free speech rights.

Washington-Agriculture Secretary Ann M. Veneman announced an awareness campaign entitled "Biosecurity for the Birds," to educate noncommercial bird owners on avian health and poultry diseases.

Washington-The Food and Drug Administration (FDA) has issued a handful of warning letters to compounding pharmacies working with human and/or animal drugs and at least two written warnings to veterinary practices.

Las Vegas-The U.S. Drug Enforce-ment Administration (DEA) doesn't do spot checks or make social calls. If agents or investigators visit a veterinary practice, there's a problem.

The FDA Investigations Operations Manual includes revised instructions regarding the release of information.

image3-84866-1384840252932.jpg

Washington-In the wake of the country's first case of mad cow disease, the United States Department of Agriculture's (USDA) ruling to ban all non-ambulatory, disabled livestock from being slaughtered may mean that the government will rely on veterinarians and producers to get access to test animals at highest risk for mad cow disease.

Scour Bos 9, from Novartis Animal Vaccines, received United States Department of Agriculture approval for administration at eight to 16 weeks prior to calving as an initial dose the first year of vaccination.

IDEXX Laboratories, Inc. has been approved by the U.S. Food and Drug Administration (FDA) to market and sell NavigatorӨ (32 percent nitazoxanide) antiprotozoal oral paste treatment for equine protozoal myeloencephalitis (EPM).

The U.S. Food and Drug Administration granted marketing approval for Metacam Injectable, a non-steroidal anti-inflammatory drug (NSAID), made by Boehringer Ingelheim Vetmedica (BI) and being distributed by Merial. Coupled with Metacam Oral Suspension, the injectable offers an effective source for relief of pain associate with canine osteoarthritis, the company says.